References
- Andujar P, Bensefa-Colas L, Descatha A. (2010). Acute and chronic cadmium poisoning. Rev Med Interne 31: 107-145.
- Bharavi K, Reddy AG, Rao GS, Kumar PR, Kumar DS, Prasadini PP. (2011). Prevention of cadmium bioaccumulation by herbal adaptogens. Indian J Pharmacol 43: 45-9.
- Blanusa M, Varnai VM, Piasek M, Kostial K. (2005). Chelators as antidotes of metal toxicity: therapeutic and experimental aspects. Curr Med Chem 12: 2771-94.
- Blumenthal SS, Ren L, Lewand DL, Krezoski SK, Petering DH. (1998). Cadmium decreases SGLT1 messenger RNA in mouse kidney cells. Toxicol Appl Pharmacol 149: 49-54.
- Chapatwala KD, Boykin M, Butts A, Rajanna B. (1982). Eff ect of intraperitoneally injected cadmium on renal and hepatic gluconeogenic enzymes in rats. Drug Chem Toxicol 5: 305-17.
- Donpunha W, Kukongviriyapan U, Sompamit K, Pakdechote P, Kukongviriyapan V, Pannangpetch P. (2011). Protective eff ect of ascorbic acid on cadmium- induced hypertension and vascular dysfunction in mice. Biometals 24: 105-15.
- Edwards JR and Prozialeck WC. (2009). Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 238: 289-93.
- Flora SJ, Pachauri V. (2010). Chelation in metal intoxication. Int J Environ Res Public Health 7: 2745-88.
- Hamidinia SA, Erdahl WL, Chapman CJ, Steinbaugh GE, Taylor RW, Pfeiff er DR. (2006). Monensin improves the eff ectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in rats. Environ. Health Persp 114: 484-93.
- Ivanova J, Pantcheva IN, Mitewa M, Simova S, Mayer-Figge H, Sheldrick WS. (2010). Crystal structures and spectral properties of new Cd(II) and Hg(II) complexes of monensic acid with diff erent coordination modes of the ligand. Cent Eur J Chem 8: 852-860.
- Ivanova J, Gluhcheva Y, Kamenova K, Arpadjan S, Mitewa M. (2012). The tetraethylammonium salt of monensic acid-An antidote for subacute cadmium intoxication: a study using an ICR mouse model. J Trace Elem Med Biol 26:279-84.
- Manna P, Sinha M, Sill PC. (2008). Amelioration of cadmium-induced cardiac impairment by taurine. Chem-Biol Inter 174: 88-97.
- Messner B, Knofl ach M, Seubert A, Ritsch A, Pfaller K, Henderson B, Shen YH, Zeller I, Willeit J, Wick G, Kiechl S, Bernhard D. (2009). Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler Trom Vasc Biol 29: 1392-8.
- Molloaoglu H, Gokcimen A, Ozguner F, Oktem F, Ahmet K, Hilimi D, Gokalp O, Cicek E. (2006). Caff eic acid phenethyl ester prevents cadmium-induced cardiac impairment in rat. Toxicol 227: 15-20.
- Nordberg GF. (2004). Cadmium and health in the 21st century--historical remarks and trends for the future. Biometals 17: 485-9.
- Nordberg GF, Jin T and Nordberg M. (1994). Subcellular targets of cadmium nephrotoxicity: cadmium binding to renal membrane proteins in animals with or without protective metallothionein synthesis. Environ Health Perspect 102(3): 191-4.
- Nordberg M and Nordberg GF. (2000). Toxicological aspects of metallothionein. Cell Mol Biol 46: 451-63.
- Peters JL, Perlstein TS, Perry ML, McNeely E, Weuve J. (2010). Cadmium exposure in association with history of stroke and heart failure. Environ Res 110: 199-206.
- Prozialeck WC, Edwards JR, Nebert DW, Woods JM, Barchowsky A, Atchison WD. (2008). The vascular system as a target of metal toxicity. Toxicol Sci 102: 207-18.
- Prozialeck WC, Edwards JR, Woods JM. (2006). The vascular endothelium as a target of cadmium toxicity. Life Sci 79: 1493-506.
- Ross R. (1999). Atherosclerosis--an infl ammatory disease. N Engl J Med 340: 115-26.
- Satarug S, Nishijo M, Ujjin P, Vanavanitkun Y, Moore MR. (2005). Cadmiuminduced nephropathy in the development of high blood pressure. Toxicol Lett 157: 57-68.
- Smetana R, Glogar D, Weidinger F, Meisinger V. (1987). Heavy metal and trace element deviations. A comparison of idiopathic dilated cardiomyopathy and coronary heart disease. Wien Med Wochenschr 137: 553-7.
- Sompamit K, Kukongviriyapan U, Donpunha W, Nakmareong S, Kukongviriyapan V. (2010). Reversal of cadmium-induced vascular dysfunction and oxidative stress by meso-2,3-dimercaptosuccinic acid in mice. Toxicol Lett 198: 77-82.
- Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Sharrett AR, Guallar E. (2010). Cadmium and peripheral arterial disease: gender diff erences in the 1999-2004 US National Health and Nutrition Examination Survey. Am J Epidemiol 172: 671-81.
- Thijssen S, Maringwa J, Faes Ch, Lambrichts I, Kerkhove EV. (2007). Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early renal damage, not predicted by blood or urine cadmium levels. Toxicol 229: 145-156.